checkpoint inhibitor-related pneumonitis
Conditions
Interventions
Cases group:No intervention
Sponsors
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: From January 2018 to June 2022, a total of 400 patients with immune checkpoint inhibitors were treated in our center, regardless of gender or age. The tumor diagnosis was in line with the Chinese norms for the diagnosis and treatment of common malignant tumors, and the diagnosis of CIP was in line with the Expert Consensus on the diagnosis and Treatment of immune checkpoint inhibitor-associated Pneumonia. The above criteria were judged by two medical oncologists. In case of disagreement, they were discussed and clarified by an associate chief physician of the medical oncologist and included in this study.
Exclusion criteria
Exclusion criteria: Interstitial pneumonia such as radiation pneumonia or severe lung infections have been diagnosed before immunotherapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| clinical features;clinical symptoms;Chest CT features; | — |
Countries
China
Contacts
Public ContactXIaowei Ye
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Outcome results
None listed